Navigation Links
Discovery Could Lead To Novel Approaches In HIV Treatment

CANVAC, the Canadian Network for Vaccines and Immunotherapeutics, has announced the development of a new method to assess how well the thymus (an organ located at the base of the neck) works and the discovery of a functional abnormality of this organ in HIV-infected individuals. The team of investigators led by Dr. Rafick-Pierre Sékaly, professor at Université de Montréal, scientist at the CHUM Research Centre, and Scientific Director and Program Leader of CANVAC, publishes today its discoveries in Immunity, a prestigious scientific journal. This work was performed in collaboration with investigators from the Research Institute of the McGill University Health Centre as well as from France and Israel.

Using only blood samples, these researchers first developed a method to assess how well the thymus functions. The thymus is involved in the development of T-lymphocytes, an essential component of the immune system. T-lymphocytes also happen to be HIV's preferred targets for infection. The researchers then used this method to study blood samples from patients that had been recently infected with HIV and found that, already in the first months following the onset of infection, thymic function is decreased. Such a decrease results in a lowered T-lymphocyte production by the thymus. These findings pave the way to the development of novel immunotherapies of HIV-infected individuals. Such immunotherapies could be also applicable to patients requiring bone marrow transplantation to cure their cancer.
'"/>

Source:CANVAC press release


Page: 1

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Promises Simpler Therapy for Sickle Cell Disease
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... findings on what they believe could be a new and helpful biomarker for ... research. Click here to read it now. , Biomarkers are components ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: